Article
Exploring the alternative lengthening of telomeres through in vitro gene editing and the study of soft tissue sarcomas
2021-01-01
Abstract excerpt
The majority of cancers reactivate telomerase to maintain their telomere length but a minority (10 to 15%) utilize an alternative lengthening of telomeres (ALT) pathway, which involves a specialized form of homologous recombination. The CTC1/STN1/TEN1 (CST) complex plays multiple roles in telomerase-expressing cells but its role in ALT remains poorly studied. As there is more than one mechanism by which telomeres...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ce88a5e6-1c8d-50c3-952f-3ad8fd6e0dcd
- DOI
- 10.25392/leicester.data.16558158.v1
